AusCann Financial Statements From 2010 to 2024
| ACNNFDelisted Stock | USD 0 0.0007 22.58% |
Check AusCann Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AusCann Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . AusCann financial statements analysis is a perfect complement when working with AusCann Group Valuation or Volatility modules.
AusCann |
AusCann Group Holdings Company Shares Outstanding Analysis
AusCann Group's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AusCann Group Shares Outstanding | 440.55 M |
Most of AusCann Group's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AusCann Group Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, AusCann Group Holdings has 440.55 M of shares currently outstending. This is 144.02% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 22.96% higher than that of the company.
AusCann Group Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AusCann Group's current stock value. Our valuation model uses many indicators to compare AusCann Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AusCann Group competition to find correlations between indicators driving AusCann Group's intrinsic value. More Info.AusCann Group Holdings is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AusCann Group's earnings, one of the primary drivers of an investment's value.About AusCann Group Financial Statements
AusCann Group stakeholders use historical fundamental indicators, such as AusCann Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although AusCann Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in AusCann Group's assets and liabilities are reflected in the revenues and expenses on AusCann Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AusCann Group Holdings. Please read more on our technical analysis and fundamental analysis pages.
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. Auscann Group operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in AusCann Pink Sheet
If you are still planning to invest in AusCann Group Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AusCann Group's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |